Tilray Brands, Inc. (TLRY)’s Potential Upside Meets a Cautious Consensus

Tilray Brands, Inc. (NASDAQ:TLRY) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, Tilray Brands, Inc. (NASDAQ:TLRY) has mixed analyst sentiment, with slightly more than 60% of analysts covering the stock assigning a Hold rating and the remaining 36% recommending buying the stock. While the target price ranges from $8.50 to $25, the median price target of $19 reflects an upside potential of 88.49%.

On December 22, Nadine Sarwat, an analyst at Bernstein, reiterated a ‘Market Perform’ rating on Tilray Brands, Inc. (NASDAQ:TLRY), while substantially raising the price target to $10 from $1.

Stokkete/Shutterstock.com

The firm highlighted President Trump’s cannabis- related Executive Order that has two aims: directing the Attorney General to take all the necessary steps to reschedule cannabis from Schedule I to III, and instructing his Administration to work with Congress to revise the statutory definition of hemp-derived cannabinoid product to incorporate many full-spectrum CBD products. This would also involve establishing a regulatory approach for these offerings and accelerating research.

Bernstein pointed out that cannabis has largely emerged as a bipartisan issue, with Gallup revealing that 64% of Americans are in favour of cannabis legalization in 2025. Despite it being a meaningful figure, it still represents a drop from the 70% peak reported in 2023.

Tilray Brands, Inc. (NASDAQ:TLRY) is a Canadian lifestyle consumer products company specializing in medical cannabis products. Incepted in 2018, the company operates through four segments: Beverage, Cannabis, Distribution, and Wellness.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.